OpusPoint Partners
It is proposed that this article be deleted because of the following concern:
If you can address this concern by improving, copyediting, sourcing, renaming, or merging the page, please edit this page and do so. You may remove this message if you improve the article or otherwise object to deletion for any reason. Although not required, you are encouraged to explain why you object to the deletion, either in your edit summary or on the talk page. If this template is removed, do not replace it. The article may be deleted if this message remains in place for seven days, i.e., after 05:31, 21 December 2024 (UTC). Find sources: "OpusPoint Partners" – news · newspapers · books · scholar · JSTOR |
Another editor has reviewed this page's proposed deletion and endorses both the proposal and the reason given above. If you remove the {{proposed deletion/dated}} tag above, please also remove this {{Proposed deletion endorsed}} tag. |
 | |
| Company type | Private Equity Investment Firm |
|---|---|
| Industry | Private equity |
| Founded | 2009 |
| Headquarters | New York, NY, United States |
Key people | Michael S. Weiss, Lindsay A. Rosenwald |
| Products | Venture capital, Consulting |
| Website | OpusPoint |
OpusPoint Partners, LLC is an investment advisory firm specializing in healthcare and life sciences.[1]
Background
[edit]Founded in 2009 by Michael S. Weiss and Lindsay A. Rosenwald, MD,[2] the firm acts as the investment manager for some portfolio private hedge funds in the healthcare and biotechnology sectors.[3]
In October 2010, OpusPoint invested approximately $3 million into National Holdings Corporation and formed a joint venture. As a result, a new investment banking firm, OPN Capital Markets, was established to leverage the resources of both companies.[4][5]
Among others, OpusPoint Partners participated in the private placement for such companies as Sunesis Pharmaceuticals, Inc. that developed Voreloxin, an anticancer drug used in acute myeloid leukemia.[6]
References
[edit]- ^ "National Holdings Corporation Completes Equity Financing Led By OpusPoint Partners; Parties To Enter Into Strategic Alliance". reuters.com. 6 Oct 2010. Retrieved 2011-06-13.
- ^ "OpusPoint Partners History". opuspointpartners.com. Retrieved 2011-06-13.
- ^ "SECURITIES AND EXCHANGE COMMISSION (FORM 8-K)". markets.on.nytimes.com. 2011. Retrieved 2011-06-13.
- ^ "National Holdings Corporation Completes Equity Financing Led By OpusPoint Partners; Parties To Enter Into Strategic Alliance". reuters.com. 6 Oct 2010. Retrieved 2011-06-13.
- ^ "National Holdings Completes Equity Financing Led by OpusPoint Partners". DailyFinance.com. 6 Oct 2010. Retrieved 2011-06-13.
- ^ "Sunesis Closes $28.5 Million Final Tranche of 2009 Private Placement". finance.yahoo.com. June 30, 2010. Retrieved 2011-06-13.
External links
[edit]